Serveur d'exploration sur le lymphœdème

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Combination of fluconazole and alpha-tocopherol in the treatment of yellow nail syndrome.

Identifieur interne : 000388 ( France/Analysis ); précédent : 000387; suivant : 000389

Combination of fluconazole and alpha-tocopherol in the treatment of yellow nail syndrome.

Auteurs : Robert Baran [France] ; Luc Thomas

Source :

RBID : pubmed:19271377

Descripteurs français

English descriptors

Abstract

Yellow nail syndrome (YNS) is an uncommon disorder that is characterized by the slow nail growth, marked thickening, and yellow to yellow-green discoloration of the fingernails or toenails. Although the etiology of YNS is unknown, a diagnosis is indicated by the concurrent presentation of the nail changes, with lymphedema and respiratory manifestations. Although lymphedema and respiratory manifestations are sometimes manageable with regimens of medical and surgical treatments, YNS treatment options are limited and often unsuccessful. For the patient, YNS can also be cosmetically unacceptable and concealment with nail polish may not always be possible. However, it is now widely accepted that the azole class of antifungals can stimulate linear nail growth. In addition, vitamin E has also been reported in the treatment of YNS with positive results. Herein, the authors report on a promising combination treatment of oral fluconazole pulse therapy and oral alpha-tocopherol (vitamin E) in 13 patients with YNS with clinical successes observed in 2 individuals and clinical cures observed in 11 subjects.

PubMed: 19271377


Affiliations:


Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:19271377

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Combination of fluconazole and alpha-tocopherol in the treatment of yellow nail syndrome.</title>
<author>
<name sortKey="Baran, Robert" sort="Baran, Robert" uniqKey="Baran R" first="Robert" last="Baran">Robert Baran</name>
<affiliation wicri:level="1">
<nlm:affiliation>Nail Disease Centre, Cannes, France. baran.r@club-internet.fr</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Nail Disease Centre, Cannes</wicri:regionArea>
<wicri:noRegion>Cannes</wicri:noRegion>
<wicri:noRegion>Cannes</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Thomas, Luc" sort="Thomas, Luc" uniqKey="Thomas L" first="Luc" last="Thomas">Luc Thomas</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2009">2009</date>
<idno type="RBID">pubmed:19271377</idno>
<idno type="pmid">19271377</idno>
<idno type="wicri:Area/PubMed/Corpus">002F49</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002F49</idno>
<idno type="wicri:Area/PubMed/Curation">002F49</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002F49</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002F49</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002F49</idno>
<idno type="wicri:Area/Ncbi/Merge">003271</idno>
<idno type="wicri:Area/Ncbi/Curation">003271</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">003271</idno>
<idno type="wicri:doubleKey">1545-9616:2009:Baran R:combination:of:fluconazole</idno>
<idno type="wicri:Area/Main/Merge">006432</idno>
<idno type="wicri:Area/Main/Curation">006355</idno>
<idno type="wicri:Area/Main/Exploration">006355</idno>
<idno type="wicri:Area/France/Extraction">000388</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Combination of fluconazole and alpha-tocopherol in the treatment of yellow nail syndrome.</title>
<author>
<name sortKey="Baran, Robert" sort="Baran, Robert" uniqKey="Baran R" first="Robert" last="Baran">Robert Baran</name>
<affiliation wicri:level="1">
<nlm:affiliation>Nail Disease Centre, Cannes, France. baran.r@club-internet.fr</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Nail Disease Centre, Cannes</wicri:regionArea>
<wicri:noRegion>Cannes</wicri:noRegion>
<wicri:noRegion>Cannes</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Thomas, Luc" sort="Thomas, Luc" uniqKey="Thomas L" first="Luc" last="Thomas">Luc Thomas</name>
</author>
</analytic>
<series>
<title level="j">Journal of drugs in dermatology : JDD</title>
<idno type="ISSN">1545-9616</idno>
<imprint>
<date when="2009" type="published">2009</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Aged</term>
<term>Antifungal Agents (administration & dosage)</term>
<term>Drug Therapy, Combination</term>
<term>Female</term>
<term>Fluconazole (administration & dosage)</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Nail Diseases (drug therapy)</term>
<term>Nail Diseases (pathology)</term>
<term>Syndrome</term>
<term>Vitamins (administration & dosage)</term>
<term>alpha-Tocopherol (administration & dosage)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Adulte d'âge moyen</term>
<term>Antifongiques (administration et posologie)</term>
<term>Association de médicaments</term>
<term>Femelle</term>
<term>Fluconazole (administration et posologie)</term>
<term>Humains</term>
<term>Mâle</term>
<term>Onychopathies (anatomopathologie)</term>
<term>Onychopathies (traitement médicamenteux)</term>
<term>Sujet âgé</term>
<term>Syndrome</term>
<term>Vitamines (administration et posologie)</term>
<term>alpha-Tocophérol (administration et posologie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en">
<term>Antifungal Agents</term>
<term>Fluconazole</term>
<term>Vitamins</term>
<term>alpha-Tocopherol</term>
</keywords>
<keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr">
<term>Antifongiques</term>
<term>Fluconazole</term>
<term>Vitamines</term>
<term>alpha-Tocophérol</term>
</keywords>
<keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr">
<term>Onychopathies</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en">
<term>Nail Diseases</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en">
<term>Nail Diseases</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr">
<term>Onychopathies</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Aged</term>
<term>Drug Therapy, Combination</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Syndrome</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Adulte d'âge moyen</term>
<term>Association de médicaments</term>
<term>Femelle</term>
<term>Humains</term>
<term>Mâle</term>
<term>Sujet âgé</term>
<term>Syndrome</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Yellow nail syndrome (YNS) is an uncommon disorder that is characterized by the slow nail growth, marked thickening, and yellow to yellow-green discoloration of the fingernails or toenails. Although the etiology of YNS is unknown, a diagnosis is indicated by the concurrent presentation of the nail changes, with lymphedema and respiratory manifestations. Although lymphedema and respiratory manifestations are sometimes manageable with regimens of medical and surgical treatments, YNS treatment options are limited and often unsuccessful. For the patient, YNS can also be cosmetically unacceptable and concealment with nail polish may not always be possible. However, it is now widely accepted that the azole class of antifungals can stimulate linear nail growth. In addition, vitamin E has also been reported in the treatment of YNS with positive results. Herein, the authors report on a promising combination treatment of oral fluconazole pulse therapy and oral alpha-tocopherol (vitamin E) in 13 patients with YNS with clinical successes observed in 2 individuals and clinical cures observed in 11 subjects.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>France</li>
</country>
</list>
<tree>
<noCountry>
<name sortKey="Thomas, Luc" sort="Thomas, Luc" uniqKey="Thomas L" first="Luc" last="Thomas">Luc Thomas</name>
</noCountry>
<country name="France">
<noRegion>
<name sortKey="Baran, Robert" sort="Baran, Robert" uniqKey="Baran R" first="Robert" last="Baran">Robert Baran</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/France/Analysis
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000388 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/France/Analysis/biblio.hfd -nk 000388 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    France
   |étape=   Analysis
   |type=    RBID
   |clé=     pubmed:19271377
   |texte=   Combination of fluconazole and alpha-tocopherol in the treatment of yellow nail syndrome.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/RBID.i   -Sk "pubmed:19271377" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1 

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024